| 000 | 01324 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513202602.0 | ||
| 264 | 0 | _c20000224 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0732-8893 | ||
| 024 | 7 |
_a10.1016/s0732-8893(99)00085-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPonce-de-León, A | |
| 245 | 0 | 0 |
_aCefepime versus ceftazidime for the treatment of serious bacterial infections. _h[electronic resource] |
| 260 |
_bDiagnostic microbiology and infectious disease _cDec 1999 |
||
| 300 |
_a263-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aCefepime |
| 650 | 0 | 4 |
_aCeftazidime _xadverse effects |
| 650 | 0 | 4 |
_aCephalosporins _xadverse effects |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aLópez-Meneses, M | |
| 700 | 1 | _aSifuentes-Osornio, J | |
| 773 | 0 |
_tDiagnostic microbiology and infectious disease _gvol. 35 _gno. 4 _gp. 263-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0732-8893(99)00085-1 _zAvailable from publisher's website |
| 999 |
_c10623025 _d10623025 |
||